| Filed On | Filing |
|---|---|
| 20 Oct 2026 |
Form 4: Fink Alexander, Director
Sold 12,580 shares ($124K) |
| 06 Oct 2026 | Merger proxy: special meeting on November 2, 2026 |
| 02 Oct 2026 |
Form 4: Zeefe Justin Matthew, Director
Granted 6,428 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Wagenheim Philip, Director
Granted 6,428 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Reisfield Derek, Director
Granted 6,428 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Prince Erik Dean, Director
Granted 6,428 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Kupriienko Serhii, Director
Granted 6,428 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Frenkel Amir, Director
Granted 6,428 Stock Option (right to buy) |
| 02 Oct 2026 |
Form 4: Antoian Edward N, Director
Granted 6,428 Stock Option (right to buy) |
| 25 Sep 2026 |
Form 3: Nestor Mykhailo, See Remarks
Holds 70,000 shares of Common Stock |
| 25 Sep 2026 | PREM14A |
| 23 Sep 2026 |
Form 4: Fink Alexander, Director
Sold 60,328 shares ($1.36M) |
| 23 Sep 2026 |
Form 4: Kupriienko Serhii, Director
Returned 1,202,065 shares to the issuer · Received 235,163 shares by exercise or conversion |
| 23 Sep 2026 | SCHEDULE 13D/A |
| 18 Sep 2026 | EFFECT |
| 17 Sep 2026 | SCHEDULE 13D/A |
| 17 Sep 2026 |
Form 4: Wagenheim Philip, Director
Disposed of 1,124,981 shares (Other Transaction) · Received 819,487 shares by exercise ($2.73M) |
| 17 Sep 2026 |
Form 4: Zeefe Justin Matthew, Director
Disposed of 223,599 shares (Other Transaction) · Sold 23,885 shares ($576K) |
| 16 Sep 2026 | 144 |
| 16 Sep 2026 | POS AM |
Loading...